Why Aehr Test Systems Stock Is Plummeting Today
Aehr Test Systems (NASDAQ: AEHR) stock is seeing huge sell-offs in Tuesday's trading. The company's share price was down 25.5% as of 11:35 a.m. ET. Meanwhile, the S&P 500 index was flat and the Nasdaq Composite index was down 0.1%.
After the market closed yesterday, Aehr published results for the second quarter of its current fiscal year -- which ended Nov. 29. In addition to sales and earnings performance for the period coming in below expectations, the company also issued forward guidance that disappointed Wall Street.
Start Your Mornings Smarter! Wake up with Breakfast news in your inbox every market day. Sign Up For Free »
Aehr Test Systems stock falls on disappointing quarterly report
Aehr posted non-GAAP (adjusted) earnings per share of $0.02 on sales of $13.45 million in its second quarter. Unfortunately, the average Wall Street estimate had called for the business to deliver an adjusted profit of $0.03 per share on revenue of $15.03 million. Revenue in the period was down roughly 37% year over year, and earnings per share were down roughly 91% compared to the prior-year period.
While the semiconductor testing equipment specialist's business is subject to cyclical trends, results in the quarter came in worse than anticipated on multiple fronts and suggest that the business could take longer to move through the down part of the current cycle. Aehr recorded bookings of just $9.2 million in the quarter, which is a bearish indicator for near-term sales performance.
What's next for Aehr Test Systems?
For the remainder of the fiscal year, Aehr reiterated its previous guidance for sales of at least $70 million and an adjusted net profit before taxes margin of at least 10%. While management kept its guidance at previous levels, it also issued cautious commentary on the demand outlook for its products.
CEO Gayn Erickson said that the growth outlook for silicon carbide products outside of China in 2025 would likely remain challenging before seeing improvement in 2026. But he also cautioned that geopolitical risks and other factors could hurt its ability to score wins in the Chinese market. On a positive note, the company does expect that testing products and other solutions for artificial intelligence processors will account for a substantial portion of its revenue this year.
Should you invest $1,000 in Aehr Test Systems right now?
Before you buy stock in Aehr Test Systems, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Aehr Test Systems wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $816,504!*
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*.
*Stock Advisor returns as of January 13, 2025
Keith Noonan has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.